Antibiotic prescribing in nursing homes in an area with low prevalence of antibiotic resistance: Compliance with national guidelines

Scandinavian Journal of Primary Health Care

Volumn 30, Issue 1, 2012, Pages 10-15

  Fagan, Mark ^a   Mæhlen, Marthe ^b   Lindbæk, Morten ^a   Berild, Dag ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anti bacterial agents; antibiotic resistance; compliance; geriatrics; infection; nursing homes

Indexed keywords

ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; INFECTION; MALE; NORWAY; NURSING HOME; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; STANDARD; STATISTICS;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFECTION; MALE; NORWAY; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84857259744     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.3109/02813432.2011.629156     Document Type: Article

References (25)

1. Statistics Norway. Available at: http://www.ssb.no/pleie/tab-2009-07-02- 01.html (accessed June 2011).
2. Blix HS, Engeland A, Litleskare I, Rønning M. Age- and gender-specific antibacterial prescribing in Norway. J Antimicrob Chemother 2007;59:971-6.
3. Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc 1991;39:963-72.
4. Blix HS, Røed J, Sti MO. Large variation in antibacterial use among Norwegian nursing homes. Scand J Infect Dis 2007;39:536-41.
5. Katz PR. Antibiotics for nursing home residents: When are they appropriate? Postgrad Med 1993;93:173-80.
6. Pettersson E, Vernby A, Mölstad S, Lundborg CS. Infections and antibiotic prescribing in Swedish nursing homes: A cross-sectional study. Scand J Infect Dis 2008;40:393-8.
7. World Health Organization Report on Infectious Diseases 2000. Overcoming antimicrobial resistance. WHO, 2000. Available at: http://www.who.int/ infectious-disease-report/2000/index.html (accessed June 2011).
8. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005;365:579-87.
9. The European Antimicrobial Resistance Surveillance System. Available at: http://www.rivm.nl/earss/ (accessed June 2011).
10. Lindbaek M, Berild D, Straand J, Hjortdahl P. Infl uence of prescription patterns in general practice on anti-microbial resistance in Norway. Br J Gen Pract 1999;49:436-40.
11. Litleskare I, Blix HS, Rønning M. Antibiotikaforbruk i Norge [Antibiotic use in Norway]. Tidsskr Nor Legeforen 2008; 128:2324-9.
12. NORM/NORM-VET 2007. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo: University Hospital of North Norway; 2008. ISSN 1502-2307.
13. Larssen KW, Jacobsen T, Bergh K, Tvete P, Kvello E, Scheel O. Outbreak of methicillin-resistant Staphylococcus aureus in two nursing homes in Central Norway. J Hosp Infect 2005;60:312-16.
14. Cohen AE, Lautenbach E, Morales KH, Linkin DR. Fluoroquinolone-resistant Escherichia coli in the long-term care setting. Am J Med 2006;119:958-63.
15. WHO Collaborating Centre for Drug Statistics Methodology (2006). ATC Index with DDDs 2007, WHO Collaborating Center, Oslo, Norway. Available at: http://www.whocc.no/ atc-ddd-index/(accessed June 2011).
16. Berild D. Smittevernloven - håndbok. Antibiotika i allmennpraksis. Oslo: Statens helsetilsyn; 2000.
17. Fagan M, Skotheim SB. Fluorokinolonbruk i sykehjem [Infectious disease Act. Manual of Antibiotics in General Practice]. Tidskr Nor Legeforen 2010;130:2022-4.
18. Bucher A, Sorknes N, Lundquist K, Rønning K. Infeksjoner og antibiotikabehandling ved sykehjem [Infections and antibiotic usage in long-term facilities]. Tidskr Nor Lægeforen 2001;7:827-30.
19. Tobiassen T, Berild D, Hjortdahl P. Bruk av systemiske antibiotika ved et norsk sykehjem [Use of antibiotics in a Norwegian nursing home: A one-year survey]. Tidskr Nor Lægeforen 2002;24:2376-8.
20. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. Risk factors for the development of extendedspectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004;23:163-7.
21. Gould CV, McDonald LC. Bench-to-bedside review: Clostridium difficile colitis. Crit Care 2008;12:203.
22. Denève C, Janoir C, Poilane I, Fantinato C, Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 2009;33(Suppl 1):S24 - 8.
23. Simonsen GS. Overvåk ing og forekomst av antibiotikaresistens i Norge [Surveillance and prevalence of antimicrobial resistance in Norway]. Tidsskr Nor Legeforen 2009; 129:623-7.
24. Gjelstad S, Dalen I, Lindbaek M. GPs' antibiotic prescription patterns for respiratory tract infections - still room for improvement. Scand J Prim Health Care 2009;27:208-15.
25. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.